Learn Before
SARS-CoV-2 and Tuberculosis (TB) Co-infection
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis and is endemic to many parts of the world. Of concern is the potential for co-infection with COVID-19 as both are spread via respiratory droplets and present with similar clinical symptoms. Due to the immunomodulatory nature of SARS-CoV-2, reactivation of latent TB infection is possible. Most diagnosis of COVID-19 may also miss TB in due to non-specific clinical features common to both diseases. TB infection may also be correlated to more severe COVID-19 disease progression, especially within endemic areas such as China and India. Active and latent TB infection can be considered to be risk factors for COVID-19. Tuberculosis should also be considered during diagnosis where patients are undergoing prolonged or unexplained clinical features.
0
1
References
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
The (in)significance of TB and COVID-19 coinfection
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity’ or ‘death'
Severe COVID-19 cases with a history of active or latent tuberculosis
Q&A: Tuberculosis and COVID-19
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
References for Secondary Infection of COVID-19 by Journal
Categories of Secondary Infections of COVID-19
SARS-CoV-2 and Human Immunodeficiency Virus (HIV) Co-infection
SARS-CoV-2 and Tuberculosis (TB) Co-infection
SARS neutralizing antibodies and SARS-CoV-2
SARS-CoV-2 and Dengue virus (DENV) in dengue‐endemic countries